Ultragenyx Pharmaceutical
RARE
RARE
164 hedge funds and large institutions have $2.16B invested in Ultragenyx Pharmaceutical in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 65 increasing their positions, 51 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
31% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 35
43% less capital invested
Capital invested by funds: $3.8B → $2.16B (-$1.64B)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
164
Holding in Top 10
–
Calls
$1.87M
Puts
$2.44M
Top Buyers
| 1 | +$31.4M | |
| 2 | +$14.7M | |
| 3 | +$13.8M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$10M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$9.78M |
Top Sellers
| 1 | -$20.9M | |
| 2 | -$19.4M | |
| 3 | -$17.3M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$16.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$16.5M |